Accessibility Menu
XOMA logo

XOMA(NASDAQ) XOMA

This security has been delisted. This page is retained for historical reference.

XOMA last closing stock price
MetricPriceDate
Last closeUSD 40.172026-07-13
XOMA stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-8.39%USD 43.852026-07-06
1 month-3.88%USD 41.792026-06-12
3 month+1.93%USD 39.412026-04-14
Year to date+51.07%USD 26.592025-12-31
1 year+48.01%USD 27.142025-07-11
3 year+142.72%USD 16.552023-07-14
5 year+24.02%USD 32.392021-07-14
Since inception-99.16%USD 4,800.481986-07-01

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

XOMA Financials

Key Financial Metrics (TTM)

Gross Margin

93.29%

Operating Margin

13.73%

Net Income Margin

86.97%

Return on Equity

30.21%

Return on Capital

4.83%

Return on Assets

11.59%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

17.54%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$33.80M

Operating Income

$4.98M

EBITDA

$50.16M

Operating Cash Flow

$6.63M

Capital Expenditure

$0.00

Free Cash Flow

$6.63M

Cash & ST Invst.

$94.96M

Total Debt

$124.73M

XOMA Performance Analysis

XOMA annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 6,027,000-84.2%
20232023-12-31USD 4,758,000-21.1%
20242024-12-31USD 28,487,000498.7%
20252025-12-31USD 52,149,00083.1%
XOMA sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-17.5%
Q32025-09-30-28.8%
Q42025-12-31-84.7%
Q12026-03-31760.2%
XOMA annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -1.98N/A
20232023-12-31USD -4.04104.1%
20242024-12-31USD -1.65-59.2%
20252025-12-31USD 1.46N/A
XOMA sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30549.0%
Q32025-09-3059.1%
Q42025-12-31-62.9%
Q12026-03-31-34.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$12.32M

-22.6%

Gross Profit

$11.42M

-25.7%

Gross Margin

92.73%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

14

N/A

Net Income

$4.47M

+88.6%

EBITDA

$8.72M

+36.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$94.96M

+2.5%

Total Debt

$124.73M

+9.0%

Accounts Receivable

$23.32M

+28.1%

Inventory

$0.00

N/A

Long Term Debt

$108.33M

+8.0%

Short Term Debt

$16.41M

+15.9%

Return on Assets

11.59%

N/A

Return on Invested Capital

2.08%

N/A

Free Cash Flow

$6.04M

+174.8%

Operating Cash Flow

$6.04M

+174.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GALTGalectin Therapeutics Inc.
$3.02+1.01%
IMABI-Mab
$2.88-0.69%
BNTCBenitec Biopharma Inc.
$12.36-1.28%
RCKTRocket Pharmaceuticals, Inc.
$3.42-0.73%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$116.22-0.07%
NVDANvidia
$219.69+0.04%
YXTYxt.com Group
$15.95+5.13%
INLFInlif
$8.32+1.62%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.